Cargando…
Managing Comorbidities, Determinants and Disability at Start and End of TB Treatment under Routine Program Conditions in China
Many patients with tuberculosis (TB) have comorbidities, risk determinants and disability that co-exist at diagnosis, during and after TB treatment. We conducted an observational cohort study in 11 health facilities in China to assess under routine program conditions (i) the burden of these problems...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383887/ https://www.ncbi.nlm.nih.gov/pubmed/37505637 http://dx.doi.org/10.3390/tropicalmed8070341 |
_version_ | 1785081021440458752 |
---|---|
author | Liu, Yuhong Lin, Yan Sun, Yuxian Thekkur, Pruthu Cheng, Changhao Li, Yuecui Shi, Yunzhen Jiang, Jun Liao, Jiong Nie, Chuangui Sun, Wenyan Liang, Chengyuan Zhang, Xiaojuan Liu, Sang Ma, Yan Berger, Selma Dar Satyanarayana, Srinath Kumar, Ajay M. V. Khogali, Mohammed Zachariah, Rony Golub, Jonathan E. Li, Liang Harries, Anthony D. |
author_facet | Liu, Yuhong Lin, Yan Sun, Yuxian Thekkur, Pruthu Cheng, Changhao Li, Yuecui Shi, Yunzhen Jiang, Jun Liao, Jiong Nie, Chuangui Sun, Wenyan Liang, Chengyuan Zhang, Xiaojuan Liu, Sang Ma, Yan Berger, Selma Dar Satyanarayana, Srinath Kumar, Ajay M. V. Khogali, Mohammed Zachariah, Rony Golub, Jonathan E. Li, Liang Harries, Anthony D. |
author_sort | Liu, Yuhong |
collection | PubMed |
description | Many patients with tuberculosis (TB) have comorbidities, risk determinants and disability that co-exist at diagnosis, during and after TB treatment. We conducted an observational cohort study in 11 health facilities in China to assess under routine program conditions (i) the burden of these problems at the start and end of TB treatment and (ii) whether referral mechanisms for further care were functional. There were 603 patients registered with drug-susceptible TB who started TB treatment: 84% were symptomatic, 14% had diabetes, 14% had high blood pressure, 19% smoked cigarettes, 10% drank excess alcohol and in 45% the 6 min walking test (6MWT) was abnormal. Five patients were identified with mental health disorders. There were 586 (97%) patients who successfully completed TB treatment six months later. Of these, 18% were still symptomatic, 12% had diabetes (the remainder with diabetes failed to complete treatment), 5% had high blood pressure, 5% smoked cigarettes, 1% drank excess alcohol and 25% had an abnormal 6MWT. Referral mechanisms for the care of comorbidities and determinants worked well except for mental health and pulmonary rehabilitation for disability. There is need for more programmatic-related studies in other countries to build the evidence base for care of TB-related conditions and disability. |
format | Online Article Text |
id | pubmed-10383887 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103838872023-07-30 Managing Comorbidities, Determinants and Disability at Start and End of TB Treatment under Routine Program Conditions in China Liu, Yuhong Lin, Yan Sun, Yuxian Thekkur, Pruthu Cheng, Changhao Li, Yuecui Shi, Yunzhen Jiang, Jun Liao, Jiong Nie, Chuangui Sun, Wenyan Liang, Chengyuan Zhang, Xiaojuan Liu, Sang Ma, Yan Berger, Selma Dar Satyanarayana, Srinath Kumar, Ajay M. V. Khogali, Mohammed Zachariah, Rony Golub, Jonathan E. Li, Liang Harries, Anthony D. Trop Med Infect Dis Article Many patients with tuberculosis (TB) have comorbidities, risk determinants and disability that co-exist at diagnosis, during and after TB treatment. We conducted an observational cohort study in 11 health facilities in China to assess under routine program conditions (i) the burden of these problems at the start and end of TB treatment and (ii) whether referral mechanisms for further care were functional. There were 603 patients registered with drug-susceptible TB who started TB treatment: 84% were symptomatic, 14% had diabetes, 14% had high blood pressure, 19% smoked cigarettes, 10% drank excess alcohol and in 45% the 6 min walking test (6MWT) was abnormal. Five patients were identified with mental health disorders. There were 586 (97%) patients who successfully completed TB treatment six months later. Of these, 18% were still symptomatic, 12% had diabetes (the remainder with diabetes failed to complete treatment), 5% had high blood pressure, 5% smoked cigarettes, 1% drank excess alcohol and 25% had an abnormal 6MWT. Referral mechanisms for the care of comorbidities and determinants worked well except for mental health and pulmonary rehabilitation for disability. There is need for more programmatic-related studies in other countries to build the evidence base for care of TB-related conditions and disability. MDPI 2023-06-26 /pmc/articles/PMC10383887/ /pubmed/37505637 http://dx.doi.org/10.3390/tropicalmed8070341 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Liu, Yuhong Lin, Yan Sun, Yuxian Thekkur, Pruthu Cheng, Changhao Li, Yuecui Shi, Yunzhen Jiang, Jun Liao, Jiong Nie, Chuangui Sun, Wenyan Liang, Chengyuan Zhang, Xiaojuan Liu, Sang Ma, Yan Berger, Selma Dar Satyanarayana, Srinath Kumar, Ajay M. V. Khogali, Mohammed Zachariah, Rony Golub, Jonathan E. Li, Liang Harries, Anthony D. Managing Comorbidities, Determinants and Disability at Start and End of TB Treatment under Routine Program Conditions in China |
title | Managing Comorbidities, Determinants and Disability at Start and End of TB Treatment under Routine Program Conditions in China |
title_full | Managing Comorbidities, Determinants and Disability at Start and End of TB Treatment under Routine Program Conditions in China |
title_fullStr | Managing Comorbidities, Determinants and Disability at Start and End of TB Treatment under Routine Program Conditions in China |
title_full_unstemmed | Managing Comorbidities, Determinants and Disability at Start and End of TB Treatment under Routine Program Conditions in China |
title_short | Managing Comorbidities, Determinants and Disability at Start and End of TB Treatment under Routine Program Conditions in China |
title_sort | managing comorbidities, determinants and disability at start and end of tb treatment under routine program conditions in china |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383887/ https://www.ncbi.nlm.nih.gov/pubmed/37505637 http://dx.doi.org/10.3390/tropicalmed8070341 |
work_keys_str_mv | AT liuyuhong managingcomorbiditiesdeterminantsanddisabilityatstartandendoftbtreatmentunderroutineprogramconditionsinchina AT linyan managingcomorbiditiesdeterminantsanddisabilityatstartandendoftbtreatmentunderroutineprogramconditionsinchina AT sunyuxian managingcomorbiditiesdeterminantsanddisabilityatstartandendoftbtreatmentunderroutineprogramconditionsinchina AT thekkurpruthu managingcomorbiditiesdeterminantsanddisabilityatstartandendoftbtreatmentunderroutineprogramconditionsinchina AT chengchanghao managingcomorbiditiesdeterminantsanddisabilityatstartandendoftbtreatmentunderroutineprogramconditionsinchina AT liyuecui managingcomorbiditiesdeterminantsanddisabilityatstartandendoftbtreatmentunderroutineprogramconditionsinchina AT shiyunzhen managingcomorbiditiesdeterminantsanddisabilityatstartandendoftbtreatmentunderroutineprogramconditionsinchina AT jiangjun managingcomorbiditiesdeterminantsanddisabilityatstartandendoftbtreatmentunderroutineprogramconditionsinchina AT liaojiong managingcomorbiditiesdeterminantsanddisabilityatstartandendoftbtreatmentunderroutineprogramconditionsinchina AT niechuangui managingcomorbiditiesdeterminantsanddisabilityatstartandendoftbtreatmentunderroutineprogramconditionsinchina AT sunwenyan managingcomorbiditiesdeterminantsanddisabilityatstartandendoftbtreatmentunderroutineprogramconditionsinchina AT liangchengyuan managingcomorbiditiesdeterminantsanddisabilityatstartandendoftbtreatmentunderroutineprogramconditionsinchina AT zhangxiaojuan managingcomorbiditiesdeterminantsanddisabilityatstartandendoftbtreatmentunderroutineprogramconditionsinchina AT liusang managingcomorbiditiesdeterminantsanddisabilityatstartandendoftbtreatmentunderroutineprogramconditionsinchina AT mayan managingcomorbiditiesdeterminantsanddisabilityatstartandendoftbtreatmentunderroutineprogramconditionsinchina AT bergerselmadar managingcomorbiditiesdeterminantsanddisabilityatstartandendoftbtreatmentunderroutineprogramconditionsinchina AT satyanarayanasrinath managingcomorbiditiesdeterminantsanddisabilityatstartandendoftbtreatmentunderroutineprogramconditionsinchina AT kumarajaymv managingcomorbiditiesdeterminantsanddisabilityatstartandendoftbtreatmentunderroutineprogramconditionsinchina AT khogalimohammed managingcomorbiditiesdeterminantsanddisabilityatstartandendoftbtreatmentunderroutineprogramconditionsinchina AT zachariahrony managingcomorbiditiesdeterminantsanddisabilityatstartandendoftbtreatmentunderroutineprogramconditionsinchina AT golubjonathane managingcomorbiditiesdeterminantsanddisabilityatstartandendoftbtreatmentunderroutineprogramconditionsinchina AT liliang managingcomorbiditiesdeterminantsanddisabilityatstartandendoftbtreatmentunderroutineprogramconditionsinchina AT harriesanthonyd managingcomorbiditiesdeterminantsanddisabilityatstartandendoftbtreatmentunderroutineprogramconditionsinchina |